BUFFALO, N.Y., April 25, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on May 3, 2012, before market open, it will report its first quarter financial results for the period ended March 31, 2012 and will host a conference call at 11:00 a.m. ET. Management will provide updates and address investor questions regarding the Company’s progress with the FDA, ongoing and pending clinical trials and general business developments.
